Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.2K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The human GABA <sub>A</sub> receptor α4 subunit variant Ile114Asn linked to epilepsy impairs membrane expression with β3 and δ subunits.

microPublication biology·2026
Same author

Emerging Topics in Neurogenomics: Summary From Inaugural Child Neurology Society Genetics Summit.

Pediatric neurology·2026
Same author

The human GABA<sub>A</sub> receptor α4 subunit variant Ile114Asn linked to epilepsy impairs membrane expression with β3 and δ subunits.

bioRxiv : the preprint server for biology·2026
Same author

2025 Consensus Clinical Management Guidelines for Niemann-Pick Disease Type C.

Journal of inherited metabolic disease·2026
Same author

Common Data Elements Regarding Social Determinants of Health in Pediatric Epilepsy Research: A Concept Mapping Study.

Pediatric neurology·2025
Same author

Sturge-Weber syndrome: an overview of history, genetics, clinical manifestations, and management.

Seminars in pediatric neurology·2024

Related Experiment Video

Updated: May 3, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
08:44

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Published on: October 17, 2025

853

Mechanism-based treatment in tuberous sclerosis complex.

Kristina Jülich1, Mustafa Sahin1

  • 1Department of Neurology, F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Pediatric Neurology
|February 4, 2014
PubMed
Summary
This summary is machine-generated.

Tuberous sclerosis complex (TSC) involves brain abnormalities due to mTOR pathway dysfunction. mTOR inhibitors show promise in treating neurological symptoms like seizures in TSC patients.

Keywords:
mTORneuronal connectivityrapamycintuberous sclerosis complex

More Related Videos

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
08:07

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin

Published on: March 24, 2023

2.2K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

3.0K

Related Experiment Videos

Last Updated: May 3, 2026

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism
08:44

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Published on: October 17, 2025

853
Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin
08:07

Label-Free Non-Linear Optics for the Study of Tubulin-Dependent Defects in Central Myelin

Published on: March 24, 2023

2.2K
Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
07:20

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy

Published on: August 9, 2024

3.0K

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Tuberous sclerosis complex (TSC) is a genetic disorder affecting the brain in nearly all patients.
  • Mutations in TSC1 or TSC2 genes disrupt mammalian target of rapamycin (mTOR) signaling, impacting cellular growth.
  • Neurological issues like intractable seizures, autism, and intellectual disability are common in TSC.

Purpose of the Study:

  • To review the role of the TSC/mTOR pathway in neuronal development and network formation.
  • To explore novel, mechanism-based treatment strategies for TSC-related neurological and behavioral symptoms.

Main Methods:

  • A literature review was conducted to identify current therapeutic challenges and emerging strategies for TSC.

Main Results:

  • Dysregulated mTOR signaling is a key target for current TSC therapies.
  • Studies indicate impaired neuronal connectivity in TSC, linked to mTOR pathway activation.
  • mTOR inhibitors, like rapamycin, have shown efficacy in animal models and initial human trials for seizure control in TSC.

Conclusions:

  • Aberrant neuronal connectivity is a significant feature of TSC.
  • mTOR inhibitors represent a promising therapeutic avenue for managing TSC symptoms.